Synthesis of TiO2 nanostructured reservoir with temozolomide:: Structural evolution of the occluded drug

被引:30
作者
Lopez, T.
Sotelo, J.
Navarrete, J.
Ascencio, J. A.
机构
[1] Inst Mexicano Petr, Mexico City 07730, DF, Mexico
[2] Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Mexico City, DF, Mexico
关键词
D O I
10.1016/j.optmat.2006.03.033
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Sol-gel synthesized nanostructured TiO2 matrix were produced with different channel sizes, where drug are immersed, producing a reservoir with Temozolomide (TMZ). This drug is particularly important for the treatment of cancer tumors, which are fundamentally a consequence of the uncontrolled reproduction of human cell. In this way the chemotherapy plays an important role in the treatment of both recurrent and newly diagnosed patients. In the handling of brain tumors TMZ has been discovered as a recent and efficient second generation drug employed in the control of advanced brain gliomas, and it is a welcome addition. Its active component binds to the cancerous DNA cells, thus preventing their disordered growth, destroying them. In this work, we report the synthesis of TiO2 nanostructured reservoir with TMZ, focusing the effort to the understanding of structural effects on the TMZ configuration by using nuclear magnetic resonance, Raman and IR spectroscopy methods. Our results establish that TMZ molecules are quite sensible to chemical processes and it produces the activation of the molecule, which is followed and understood with help of quantum molecular simulation methods. The study of the molecules allows determining the conditions that produce the activation and chemical selectivity of the molecules, which determines the conditions of synthesis. This information gives parameters for the reservoir structural and chemical optimization. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:88 / 94
页数:7
相关论文
共 23 条
[1]   Synthesis and theoretical analysis of samarium nanoparticles: Perspectives in nuclear medicine [J].
Ascencio, JA ;
Rincon, AC ;
Canizal, G .
JOURNAL OF PHYSICAL CHEMISTRY B, 2005, 109 (18) :8806-8812
[2]  
Ascencio-Gutiérrez JA, 2000, AFINIDAD, V57, P180
[3]  
Balis F., 1995, P AN M AM SOC CLIN, V14, P461
[4]   CANCER-RESEARCH CAMPAIGN PHASE-II TRIAL OF TEMOZOLOMIDE IN METASTATIC MELANOMA [J].
BLEEHEN, NM ;
NEWLANDS, ES ;
LEE, SM ;
THATCHER, N ;
SELBY, P ;
CALVERT, AH ;
RUSTIN, GJS ;
BRAMPTON, M ;
STEVENS, MFG .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) :910-913
[5]   Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma [J].
Bower, M ;
Newlands, ES ;
Bleehen, NM ;
Brada, M ;
Begent, RJH ;
Calvert, H ;
Colquhoun, I ;
Lewis, P ;
Brampton, MH .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (06) :484-488
[6]   From molecules to solids with the DMol3 approach [J].
Delley, B .
JOURNAL OF CHEMICAL PHYSICS, 2000, 113 (18) :7756-7764
[7]  
GARCIASALINAS L, 2001, NUC MED BIOL, V28, P319
[8]   Structure and stability of small TiO2 nanoparticles [J].
Hamad, S ;
Catlow, CRA ;
Woodley, SM ;
Lago, S ;
Mejías, JA .
JOURNAL OF PHYSICAL CHEMISTRY B, 2005, 109 (33) :15741-15748
[9]  
LOPEZ T, IN PRESS J BIOM MA A
[10]   Study of the sodium phenytoin effect on the formation of sol-gel SiO2 nanotubes by TEM [J].
Lópeze, T ;
Asomoza, M ;
Picquart, M ;
Castillo-Ocampo, P ;
Manjarrez, J ;
Vázquez, A ;
Ascencio, JA .
OPTICAL MATERIALS, 2005, 27 (07) :1270-1275